Issue Date: March 2, 1998
Issued by: Center for Drug Evaluation and Research
Topic(s): Clinical – Medical, Pediatric Product Development
Status: Final
Psychoactive Drugs in Infants and Children–Clinical Evaluation
The FDA published Good Guidance Practices in February 1997. This guidance was developed and issued prior to that date.
Download the Guidance Document
